DOP2002000419A - SELF-EMULSIONING FORMULATIONS OF INHIBITORS OF THE ESTER CHOLESTERILE TRANSFER PROTECTION. - Google Patents
SELF-EMULSIONING FORMULATIONS OF INHIBITORS OF THE ESTER CHOLESTERILE TRANSFER PROTECTION.Info
- Publication number
- DOP2002000419A DOP2002000419A DO2002000419A DO2002000419A DOP2002000419A DO P2002000419 A DOP2002000419 A DO P2002000419A DO 2002000419 A DO2002000419 A DO 2002000419A DO 2002000419 A DO2002000419 A DO 2002000419A DO P2002000419 A DOP2002000419 A DO P2002000419A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- self
- inhibitors
- cholesterile
- emulsioning
- formulations
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 239000004094 surface-active agent Substances 0.000 abstract 3
- 239000003354 cholesterol ester transfer protein inhibitor Substances 0.000 abstract 2
- 229940125881 cholesteryl ester transfer protein inhibitor Drugs 0.000 abstract 1
- 239000006184 cosolvent Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Inhibidores de CETP que tienen mejor solubilidad y biodisponibilidad en un vehículo lipófilo que comprende un aceite digerible, un disolvente lipófilo o un tensioactivo. Tales composiciones preferidas son autoemulsionantes o automicroemulsionantes y comprenden 1. un inhibidor de CETP; 2. un codisolvente; 3. un tensioactivo que tiene un HLB de 1 a 8; 4. un tensioactivo que tiene un HLB de 8 a 20; y 5. opcionalmente, un aceite digerible.CETP inhibitors that have better solubility and bioavailability in a lipophilic vehicle comprising a digestible oil, a lipophilic solvent or a surfactant. Such preferred compositions are self-emulsifying or self-emulsifying and comprise 1. a CETP inhibitor; 2. a co-solvent; 3. a surfactant having an HLB of 1 to 8; 4. a surfactant having an HLB of 8 to 20; and 5. optionally, a digestible oil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DO2002000419A DOP2002000419A (en) | 2002-06-18 | 2002-06-18 | SELF-EMULSIONING FORMULATIONS OF INHIBITORS OF THE ESTER CHOLESTERILE TRANSFER PROTECTION. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DO2002000419A DOP2002000419A (en) | 2002-06-18 | 2002-06-18 | SELF-EMULSIONING FORMULATIONS OF INHIBITORS OF THE ESTER CHOLESTERILE TRANSFER PROTECTION. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2002000419A true DOP2002000419A (en) | 2003-01-15 |
Family
ID=44261084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2002000419A DOP2002000419A (en) | 2002-06-18 | 2002-06-18 | SELF-EMULSIONING FORMULATIONS OF INHIBITORS OF THE ESTER CHOLESTERILE TRANSFER PROTECTION. |
Country Status (1)
| Country | Link |
|---|---|
| DO (1) | DOP2002000419A (en) |
-
2002
- 2002-06-18 DO DO2002000419A patent/DOP2002000419A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY27344A1 (en) | SELF-EMULSIONING FORMULATIONS | |
| ATE420619T1 (en) | OILY FOAMABLE AEROSOL COMPOSITION | |
| ATE340238T1 (en) | HAND CLEANING PRODUCTS | |
| ATE398997T1 (en) | SELF-NANOEMULSIFIING OILY FORMULATION FOR ADMINISTRATION OF POORLY WATER-SOLUBLE MEDICINAL PRODUCTS | |
| HRP20080235T3 (en) | FORMULATION OF VACCINE CONTAINING OIL-IN-WATER EMULSION | |
| ATE365536T1 (en) | SOLVENT SYSTEMS FOR PHARMACEUTICAL PRODUCTS | |
| CO5600999A2 (en) | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE INHIBITORS OF VALSARTAN AND NEUTRAL ENDOPEPTIDASE | |
| BR0115673B1 (en) | edible spreadable emulsion and process for preparing a spreadable edible water-in-oil emulsion | |
| UA94404C2 (en) | Novel vaccine formulations | |
| UY26338A1 (en) | DISPERSIBLE FORMULATIONS CONTAINING LIPASE INHIBITORS | |
| ES2168271T3 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINS. | |
| PE20020336A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING A LIPASE INHIBITOR AND A BILIARY ACID SEQUESTRANT | |
| BR0000126A (en) | Adjuvants for use in vaccines | |
| SE0000774D0 (en) | New formulation | |
| ATE417090T1 (en) | STABILIZATION OF ESTER CONCENTRATES OF POLYUNSATURATED FATTY ACIDS | |
| NO20034139L (en) | Solid orally dispersible pharmaceutical formulations | |
| DE60000223D1 (en) | O / W emulsion containing fibers and their use in cosmetics | |
| ATE516016T1 (en) | SELF-EMULSIFYING FORMULATIONS OF CETP INHIBITORS | |
| NO20031909L (en) | Self-emulsifying oral dosage formulations of pyranone protease inhibitors | |
| PE20030230A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING A LIPASE INHIBITOR AND A SACROSE FATTY ACID ESTER | |
| MY138172A (en) | Pharmaceutical compositions based on azetidine derivatives | |
| PL328916A1 (en) | Compositions containing inhibitors of hiv protease, such as vx 478 and water-soluble vitamin e compound such as vitamin e-tpgs | |
| DE60312199D1 (en) | STEROLESTER AND FOLIC ACID WATER-IN-OIL EMULSION | |
| WO2002053120A3 (en) | Cosmetic and dermatological light protection formulations containing benzotriazole derivatives and surfactant sucrose esters | |
| IT1318401B1 (en) | N-DESACETYLTHIOCOLCHYCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN. |